Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Cellular Proliferation Imaging Using [18F] Fluorothymidine (FLT) Positron Emission Tomography (PET) in Brain Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02167204
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:27.506770+00:00
Published At
2020-01-13T00:00:00+00:00
Record Updated At
2020-01-13
Results Posted At
2020-01-13
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Metastatic Malignant Neoplasm in the Brain", "Primary Brain Neoplasm", "Recurrent Brain Neoplasm"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2020-01-13"
protocolSection.identificationModule.nctId
"NCT02167204"
protocolSection.identificationModule.officialTitle
"Cellular Proliferation Imaging Using [18F] Fluorothymidine (FLT) Positron Emission Tomography (PET) in Brain Tumors"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2020-01-13"

Study condition terms

  • Metastatic Malignant Neoplasm in the Brain (protocolSection.conditionsModule.conditions)
  • Primary Brain Neoplasm (protocolSection.conditionsModule.conditions)
  • Recurrent Brain Neoplasm (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.